ApprovalTrail

Approval · Notice of Compliance 11409 · 2010

LORAZEPAM: Notice of Compliance 11409

Issued May 26, 2010

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
11409
Date
May 26, 2010
Company
Sanis Health Inc.Brampton, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
New manufacturer and product name
Therapeutic class
Anxiolytic / Sedative

Products in this notice

BrandDINStatus today
LORAZEPAM02351072Cancelled Post Market
LORAZEPAM02351080Cancelled Post Market
LORAZEPAM02351099Cancelled Post Market

Medicinal ingredients